Skip to main content
Equibles

Eric Smith

Analyst

Cancer Fitzgerald

Equibles does not estimate personal net worth.

About Eric Smith

Eric Smith is recorded as Analyst at Cancer Fitzgerald. Eric Smith has spoken on 1 earnings call across 1 company, most recently for Legend Biotech Corp on May 12, 2026. The companies whose calls Eric Smith spoke on are classified in the Healthcare sector.

Eric Smith on recent calls

“Maybe just a quick follow-up on the Cartitude 5 event rate. I think at one point we had expected it would be possible to have data toward the end of Is that still the case, Alan?”
Analyst — Cancer Fitzgerald, Legend Biotech Corp Q1 FY2026 Earnings Call ·

Affiliation history

  • Cancer Fitzgerald

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity